NCT01820260View on ClinicalTrials.gov

Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

395

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Actinic Keratosis
Interventions
DRUG

Ingenol mebutate gel

DRUG

placebo

Trial Locations (1)

46032

Laser & Skin Surgery Center of Inidana, Carmel

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY